To do so, they recruited 384 individuals for a randomized, double-blind, placebo-controlled trial in Sweden. Patients were an average age of 57 years and had moderate-to-severe alcohol use disorder.

Varenicline: The Newest Agent for Smoking Cessation Lisa A. Potts; Candice L. Garwood Disclosures Am J Health Syst Pharm. 2007;64 (13):1381-1384. 0 ...

Results showed the greatest reduction in alcohol consumption among those who received the combination therapy. Varenicline alone also produced a measurable effect. The outcomes were assessed using ...

It suggests that a combination of varenicline and bupropion is a well-tolerated, safe, and effective treatment option for this condition. This represents a significant advancement in addressing the ...

Results Users of varenicline were younger, reported more time spent with urges to smoke at baseline, and were less likely to stop abruptly during their last quit attempt (all p < 0.01).

The Food and Drug Administration has given Aurobindo the green light for varenicline tablets, 0.5 mg and 1 mg. Aurobindo Pharma’s varenicline tablets are the generic of PF Prism C.V.’s Chantix ...